These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7391926)

  • 1. [Monoamine oxidase and its inhibition (author's transl)].
    Gérardy J
    J Pharm Belg; 1980; 35(2):133-42. PubMed ID: 7391926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in multiple forms, type A and type B, of mitochondrial monoamine oxidase (author's transl)].
    Kinemuchi H; Kamijo K
    Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1069-86. PubMed ID: 7025101
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts from the symposium Monoamine oxidase and disease: prospects for therapy with reversible inhibitors. Paris, October 26-28, 1983.
    Encephale; 1983; 9(2 Suppl 1):1A-98A. PubMed ID: 6641619
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of brain monoamine oxidase by some CNS depressants.
    Bellin JS; Sorrentino GM
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):673-80. PubMed ID: 4456499
    [No Abstract]   [Full Text] [Related]  

  • 6. Rat heart monoamine oxidase: antagonism between d-amphetamine, oleic and arachidonic acids and monoamine oxidase inhibitors.
    Sen R; Parmar SS; Guha SR
    Proc West Pharmacol Soc; 1979; 22():109-13. PubMed ID: 515037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histocytochemical findings on in vitro and in vivo inhibition of monoamine oxidases].
    Couteaux R; Bouchaud C; Gautron J
    Actual Pharmacol (Paris); 1965; 18():33-68. PubMed ID: 5335795
    [No Abstract]   [Full Text] [Related]  

  • 8. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M; Semmel M; Schor JM
    Enzymologia; 1968 Jul; 34(5):299-303. PubMed ID: 5672567
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
    Horita A
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Monoamine oxidase from rat reticulocytes: subcellular localization of the enzyme activity and effects of irreversible non-hydrazine inhibitors.
    Quiring K; Hubertus S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R83. PubMed ID: 1143505
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart.
    Raffel DM; Wieland DM
    J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of circulating and tissue eosinophils in rats after administration of reserpine associated with serotonin antagonists and after inhibition of monoamine oxidase activity].
    Capelli A; Jasonni V; Piccaluga A
    G Clin Med; 1967 Jun; 48(6):645-55. PubMed ID: 5614475
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M; Glover V; Clow A; Jarman J
    Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytosol monoamine oxidase in the rat liver].
    Moskvitina TA; Medvedev AE
    Vopr Med Khim; 2000; 46(1):48-51. PubMed ID: 10802886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis.
    Medvedev AE; Ramsay RR; Ivanov AS; Veselovsky AV; Shvedov VI; Tikhonova OV; Barradas AP; Davidson CK; Moskvitina TA; Fedotova OA; Axenova LN
    Neurobiology (Bp); 1999; 7(2):151-8. PubMed ID: 10591049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
    Hassler R; Bak IJ
    Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple forms of monoamine oxidase (author's transl)].
    Kaminski K; Matuszewski W
    Postepy Biochem; 1975; 21(4):369-82. PubMed ID: 810780
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors.
    Hadizadeh F; Ghodsi R
    Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.